Oren Becker

This inventor holds 27 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Epix Delaware, Inc., Vidac Pharma Ltd., Epix Pharmaceuticals, Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oren Becker. Retrieved from https://idiyas.com/inventor/oren-becker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 11)

% Patents Active = 51.9

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 118(Granted Patents)

Location History:

Mevaseret Zion, IL (2006 - 2016)
Mevasseret Zion, IL (2014 - 2024)

Company Filing History:

Epix Pharmaceuticals, Inc.

patents

4. 2 out of 51

Microdose Therapeutx, Inc.

Dynamix Pharmaceuticals Ltd.

Nanotherapeutics, Inc.

patents

9. 1 out of 1

Predix Pharmaceuticals Holdings, Inc.

11. 1 out of 834,570

Other

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Hexokinase-2

Piperazine Derivatives

Adenosine Analogs

Thienopyridinone Compounds

CNS Disorders

S1P Receptor Modulators

Jasmonate Compounds

PKM2 Modulation

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527782 - Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers (2026-01-20),

2. 12162868 - Piperazine derivatives, pharmaceutical compositions and methods of use thereof (2024-12-10),

3. 12083111 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2024-09-10),

4. 11905250 - Methods for preparation of jasmonate compounds (2024-02-20),

5. 11266639 - Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers (2022-03-08),

6. 11096935 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2021-08-24),

7. 11084807 - Piperazine derivatives, pharmaceutical compositions and methods of use thereof (2021-08-10),

8. 10682346 - Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses (2020-06-16),

9. 9255121 - Adenosine analogs and their use (2016-02-09),

10. 8937065 - Compositions and methods for modulating a kinase (2015-01-20),

11. 8692001 - Sulfonamides for the modulation of PKM2 (2014-04-08),

12. 8604021 - Substituted arylamine compounds and methods of treatment (2013-12-10),

13. 8569259 - Adenosine analogs and their use (2013-10-29),

14. 7982040 - Thienopyridinone compounds and methods of treatment (2011-07-19),

15. 7968538 - Substituted arylamine compounds and methods of treatment (2011-06-28),

Title: Inventor Oren Becker

Introduction: Oren Becker, a talented inventor hailing from Mevaseret Zion, IL, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Oren Becker holds several patents in various technological areas, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Oren Becker has consistently demonstrated a keen eye for innovation, leading to the development of cutting-edge technologies that have revolutionized industries.

Collaborations: Oren Becker has collaborated with top research institutions, leading companies, and brilliant minds in the field, further solidifying his reputation as a visionary inventor.

Conclusion: In conclusion, Oren Becker's passion for innovation and his relentless pursuit of excellence have cemented his legacy as a pioneering inventor in the world of technology.

Profile summary based on public USPTO records.